Decipher Genomics Resource News Today

Researchers have found that genomic risk distribution can vary widely across clinical stage groups among patients with prostate cancer. Researchers have found that genomic risk distribution can vary widely across clinical stage groups among patients with prostate cancer.

Studies presented at SUO 2023 have shed new light on risk stratification and novel treatments in prostate cancer. Studies presented at SUO 2023 have shed new light on risk stratification and novel treatments in prostate cancer.

Researchers have found that genomic risk distribution can vary widely across clinical stage groups among patients with prostate cancer. Researchers have found that genomic risk distribution can vary widely across clinical stage groups among patients with prostate cancer.

The research was aided by the Decipher Genomics Resource for Intelligent Discovery, which helped derive the gene signatures used during the analysis.

New data are from a retrospective analysis of the Phase 2 STREAM trial ...

FN Media Group Presents USA News Group News Commentary VANCOUVER, BC, May 31, 2023 /PRNewswire/ -- USA News Group - With this year's Annual Meeting of the American Society of Clinical

/PRNewswire/ -- USA News Group - With this years Annual Meeting of the American Society of Clinical Oncology (ASCO 2023) less than 30 days away, theres...

FinancialContent fully hosted finance channel

Veracyte, Inc. announced that new data to be shared at the 2023 American Society of Clinical Oncology Annual Meeting demonstrate the ability of the company’s Decipher Genomics Resource for... | June 11, 2023

Veracyte, Inc. announced that data published in the journal Cancer show the ability of a novel gene expression signature to classify prostate cancer into distinct molecular subtypes that may inform... | May 3, 2023